The Lancet Oncology Oncology

Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →